AGIOS PHARMACEUTICALS INC (AGIO) Institutional Shareholders

AGIOS PHARMACEUTICALS INC (AGIO) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $2.22B in AGIO holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of AGIO tracked by InsiderSet, reporting ownership valued at approximately $239.58M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $212.73M, representing an estimated loss of -11.21% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 51% of the total disclosed AGIO value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., State Street Corp, Lynx1 Capital Management Lp, and several other long-term asset managers with concentrated positions in AGIOS PHARMACEUTICALS INC (AGIO).

This page ranks the largest institutional AGIO shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

230

Total Reported Value

$2.22B

Largest Holder

Blackrock, Inc.

Largest Position

$239.58M

Insider Transactions (90d)

4

Latest Filing Quarter

Q2 2026

New Institutional Positions

49

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.00%6,455,997$239,582,050$212,725,101-$26,856,949-11.21%
State Street Corp0.00%3,533,633$131,144,972$116,433,207-$14,711,765-11.22%
Lynx1 Capital Management Lp14.62%3,408,937$126,505,652$112,324,474-$14,181,178-11.21%
D. E. Shaw & Co., Inc.0.07%3,107,005$115,300,956$102,375,815-$12,925,141-11.21%
Vanguard Portfolio Management Llc0.00%2,898,197$107,552,091$95,495,591-$12,056,500-11.21%
Vanguard Capital Management Llc0.00%2,681,845$99,523,268$88,366,793-$11,156,475-11.21%
Armistice Capital, Llc2.46%2,400,000$89,064,000$79,080,000-$9,984,000-11.21%
Erste Asset Management Gmbh0.64%2,154,900$81,972,396$71,003,955-$10,968,441-13.38%
Nomura Asset Management International Inc.0.12%2,110,809$78,332,000$69,551,157-$8,780,843-11.21%
Geode Capital Management, Llc0.00%1,574,268$58,433,490$51,872,131-$6,561,359-11.23%
Susquehanna International Group, Llp0.05%1,375,558$51,046,957$45,324,636-$5,722,321-11.21%
Adar1 Capital Management, Llc2.25%1,288,053$47,799,647$42,441,346-$5,358,301-11.21%
Bnp Paribas Asset Management Holding S.A.0.05%1,280,044$47,502,433$42,177,450-$5,324,983-11.21%
Dimensional Fund Advisors Lp0.01%1,248,738$46,345,467$41,145,917-$5,199,550-11.22%
Gw&K Investment Management, Llc0.35%1,206,615$44,777,000$39,757,964-$5,019,036-11.21%
Goldman Sachs Group Inc0.00%1,150,932$42,711,087$37,923,209-$4,787,878-11.21%
Ubs Group Ag0.01%985,831$36,584,189$32,483,131-$4,101,058-11.21%
Morgan Stanley0.00%963,256$35,746,487$31,739,285-$4,007,202-11.21%
Nuveen, Llc0.01%873,560$32,417,811$28,783,802-$3,634,009-11.21%
Arrowstreet Capital, Limited Partnership0.01%810,530$30,078,768$26,706,964-$3,371,804-11.21%
Foresite Capital Management Vi Llc4.53%785,000$29,131,350$25,865,750-$3,265,600-11.21%
Citadel Advisors Llc0.02%732,687$27,190,015$24,142,037-$3,047,978-11.21%
Aqr Capital Management Llc0.01%684,340$25,395,858$22,549,003-$2,846,855-11.21%
Parkman Healthcare Partners Llc2.55%669,046$24,828,297$22,045,066-$2,783,231-11.21%
Scs Capital Management Llc0.21%612,850$22,742,864$20,193,408-$2,549,457-11.21%
Qube Research & Technologies Ltd0.02%597,638$22,178,346$19,692,172-$2,486,174-11.21%
Northern Trust Corp0.00%554,709$20,585,250$18,277,662-$2,307,588-11.21%
Defilade Capital Management, L.P.2.72%546,848$20,293,529$18,018,642-$2,274,887-11.21%
Charles Schwab Investment Management Inc0.00%538,128$19,969,930$17,731,318-$2,238,612-11.21%
Two Sigma Investments, Lp0.01%536,380$19,905,062$17,673,721-$2,231,341-11.21%
Rock Springs Capital Management Lp0.96%532,563$19,763,413$17,547,951-$2,215,462-11.21%
Schonfeld Strategic Advisors Llc0.10%520,083$19,300,279$17,136,735-$2,163,544-11.21%
Bank Of America Corp0.00%507,869$18,847,034$16,734,284-$2,112,750-11.21%
Point72 Asset Management, L.P.0.03%506,344$18,790,426$16,684,035-$2,106,391-11.21%
Jane Street Group, Llc0.01%492,598$18,280,312$16,231,104-$2,049,208-11.21%
Legal & General Group Plc0.00%434,719$16,132,422$14,323,991-$1,808,431-11.21%
Vanguard Fiduciary Trust Co0.00%395,868$14,690,661$13,043,851-$1,646,810-11.21%
Panagora Asset Management Inc0.04%373,931$13,876,579$12,321,026-$1,555,553-11.21%
Kennedy Capital Management Llc0.25%373,230$13,850,565$12,297,929-$1,552,636-11.21%
Jpmorgan Chase & Co0.00%359,756$13,783,528$11,853,960-$1,929,568-14.00%
Connor, Clark & Lunn Investment Management Ltd.0.03%359,550$13,342,901$11,847,173-$1,495,728-11.21%
Squarepoint Ops Llc0.02%321,138$11,917,431$10,581,497-$1,335,934-11.21%
Bnp Paribas Financial Markets0.01%269,383$9,996,803$8,876,170-$1,120,633-11.21%
Algert Global Llc0.11%248,007$9,203,540$8,171,831-$1,031,709-11.21%
Price T Rowe Associates Inc0.00%218,966$8,127,000$7,214,930-$912,070-11.22%
Palo Alto Investors Lp1.10%213,601$7,926,733$7,038,153-$888,580-11.21%
Tetragon Partners Gp Ltd1.24%205,579$7,629,037$6,773,828-$855,209-11.21%
Bank Of New York Mellon Corp0.00%198,685$7,373,215$6,546,671-$826,544-11.21%
Jump Financial, Llc0.06%182,773$6,782,706$6,022,370-$760,336-11.21%
Invesco Ltd.0.00%168,153$6,240,157$5,540,641-$699,516-11.21%
Showing 50 of 230

Frequently asked questions about AGIO

  • Who owns the most AGIO stock?

    The largest holders of AGIO are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for AGIOS PHARMACEUTICALS INC (AGIO).

  • Is AGIO widely held by superinvestors?

    Many widely followed stocks like AGIO appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly AGIO is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.